SCHEMBL10288409

SCHEMBL10288409

N#Cc1c(N2CCOCC2)sc(C=O)c1C(F)c1ccc2ccccc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.37
PIK3CA P42336 9/20 0.35
PIK3R1 P27986 5/20 0.34
MTOR P42345 5/20 0.34
PIK3CD O00329 3/20 0.34
PIK3CB P42338 3/20 0.34
PIK3CG P48736 3/20 0.34
HPGD P15428 2/20 0.34
MAPK1 P28482 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
KDM4E B2RXH2 3/20 0.34
MAPT P10636 2/20 0.34
NSD2 O96028 1/20 0.34
LMNA P02545 1/20 0.34
TSHR P16473 1/20 0.34
CASP1 P29466 1/20 0.34
HTT P42858 1/20 0.34
CASP7 P55210 1/20 0.34
CASP6 P55212 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10288574 0.89 HPGD (0.38) ALDH1A1PIK3CAPIK3R1MTORHPGD
SCHEMBL10288594 0.86 ALDH1A1 (0.36) ALDH1A1PIK3CAPIK3R1MTORPIK3CD
SCHEMBL10288561 0.85 PIK3CA (0.50) PIK3CAPIK3R1MTORPIK3CDPIK3CB
SCHEMBL10288607 0.84 SLC6A2 (0.36) ALDH1A1PIK3CAPIK3R1HPGDMAPK1
SCHEMBL10288191 0.82 PIK3CA (0.35) ALDH1A1PIK3CAPIK3R1HPGDMAPK1
SCHEMBL10288591 0.81 PIK3CA (0.36) ALDH1A1PIK3CAPIK3R1MTORPIK3CD
SCHEMBL10288559 0.77 KDM4E (0.39) ALDH1A1PIK3CAPIK3R1MTORPIK3CD
SCHEMBL10308588 0.76 HPGD (0.38) ALDH1A1PIK3CAHPGDMAPK1NPSR1
SCHEMBL10006005 0.75 PIK3CA (0.50) PIK3CAPIK3R1HPGDMAPK1NPSR1
SCHEMBL10288308 0.74 PIK3CA (0.49) ALDH1A1PIK3CAPIK3R1HPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120172345-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-07-05 US disclosed
WO-2012021696-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-02-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120172345-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 ALDH1A1 429/4885PIK3CA 5/4885PIK3R1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.